 |
|
Applying 'supply and demand' business principles to treat infectious diseases worldwide
November 18, 2008Clinton Foundation researcher to present drug forecasting method for anti-malarial treatments at the American Society of Tropical Medicine and Hygiene Annual Meeting
Treating infectious diseases while meeting escalating costs to do so continues to pose worldwide challenges, with one of the main issues being the ability to provide an adequate supply of drugs to treat infectious diseases. While this may sound simple, ensuring a sufficient supply of effective drugs to each country that needs them remains a challenge until the demand for those drugs is accurately predicted and understood. A new and improved scientific method to forecast the demand for a key anti-malarial treatment may be the key for how science and economics can and should intersect to maintain low-cost, high-quality drugs to combat infectious diseases. According to Justin Cohen, M.P.H., Ph.D., such a forecast is crucial in order to supply enough medications to meet demand -- especially since demand has the potential to rise very rapidly as old drugs lose effectiveness and governments switch to new drugs.
Dr. Cohen and his team from the Clinton Foundation started looking for patterns in how funding for drugs is disbursed around the world and used those patterns to forecast how future funding will look. The team used a similar approach to forecasting the demand for HIV/AIDS treatments in Africa. It worked so well that the team decided to set its sights on the treatment of malaria, which now affects 300-500 million people per year - 1 million of whom die from the disease. The cost to Africa's economy alone is estimated to be $12 billion per year.
The quantitative method centers on the acquisition of a chief anti-malarial ingredient, artemisinin, which comes from plants and is used in malaria treatments. One of the challenges with artemisinin-based combination therapy (ACT) is it can take up to two years for the plants to grow, extract the artemisinin and then for pharmaceutical companies to develop the drugs. If demand isn't accurately predicted, it can lead to a shortage of drugs, driving up the cost for countries to buy them. Conversely, an oversupply can lead to drugs "going bad" as they sit on the shelf past their expiration dates. This is why forecasting demand is vital.
Dr. Cohen will explore the following points at the ASTMH Annual Meeting, December 7-11 in New Orleans:
* The anti-malarial world, from farmers up to drug producers, was disorganized and inefficient because there was little understanding of the demand for treatments. Past forecasts, including by the World Health Organization, vastly overstated expected demand;
* The first-ever robust and scenario-based global forecast of ACT demand, which shows that demand will at least double over the coming four years and could grow by as much as 327 percent to over 400 million treatment packs if a global ACT subsidy is launched;
* The forecast helped to support the signing of agreements with suppliers to reduce the volatility in artemisinin supply, reduce drug prices, and help ensure access to high-quality, low-cost drugs.
American Society of Tropical Medicine and Hygiene
The quantitative method centers on the acquisition of a chief anti-malarial ingredient, artemisinin, which comes from plants and is used in malaria treatments. One of the challenges with artemisinin-based combination therapy (ACT) is it can take up to two years for the plants to grow, extract the artemisinin and then for pharmaceutical companies to develop the drugs. If demand isn't accurately predicted, it can lead to a shortage of drugs, driving up the cost for countries to buy them. Conversely, an oversupply can lead to drugs "going bad" as they sit on the shelf past their expiration dates. This is why forecasting demand is vital.
Dr. Cohen will explore the following points at the ASTMH Annual Meeting, December 7-11 in New Orleans:
* The anti-malarial world, from farmers up to drug producers, was disorganized and inefficient because there was little understanding of the demand for treatments. Past forecasts, including by the World Health Organization, vastly overstated expected demand;
* The first-ever robust and scenario-based global forecast of ACT demand, which shows that demand will at least double over the coming four years and could grow by as much as 327 percent to over 400 million treatment packs if a global ACT subsidy is launched;
* The forecast helped to support the signing of agreements with suppliers to reduce the volatility in artemisinin supply, reduce drug prices, and help ensure access to high-quality, low-cost drugs.
American Society of Tropical Medicine and Hygiene
Infectious Diseases Current Events and Infectious Diseases News RSSSchool closure could reduce swine flu transmission by 21 percent
A survey carried out in eight European countries has shown that closing schools in the event of an infectious disease pandemic could have a significant role in reducing illness transmission.
New study finds MRSA on the rise in hospital outpatients
The community-associated strain of the deadly superbug MRSA-an infection-causing bacteria resistant to most common antibiotics-poses a far greater health threat than previously known and is making its way into hospitals, according to a study in the December issue of Emerging Infectious Diseases.
Barn Personnel Experience Higher-Than Average Rates of Respiratory Symptoms
The estimated 4.6 million Americans involved in the equine industry may be at risk of developing respiratory symptoms due to poor air quality in horse barns.
Preventing H1N1 spread to health care workers: Dilemma, debate and confusion
A commentary in the December issue of The Lancet Infectious Diseases brings to light the gaps in knowledge on the transmission of a common pathogen - the influenza virus - and its impact on decisions about how best to protect health care workers.
New findings suggest strategy to help generate HIV-neutralizing antibodies
New discoveries about anti-HIV antibodies may bring researchers a step closer to creating an effective HIV vaccine, according to a new paper co-authored by scientists at the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
The Protein Srebp2 Drives Cholesterol Formation in Prion-Infected Neuronal Cells Which May Promote Prion-Dependent Diseases
The regulating protein Srebp2 drives cholesterol formation, which prions need for their propagation, in prion-infected neuronal cells.
Texas A&M Researchers Examine How Viruses Destroy Bacteria
Viruses are well known for attacking humans and animals, but some viruses instead attack bacteria. Texas A&M University researchers are exploring how hungry viruses, armed with transformer-like weapons, attack bacteria, which may aid in the treatment of bacterial infections.
Pivotal study for PSD502 -- the first potential treatment for premature ejaculation
At the annual meeting of the Sexual Medicine Society of North America (SMSNA), Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC ("Plethora" - AIM:PLE)., today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE).
Research calls for better assessment of tests for tuberculosis, HIV/AIDS and malaria
A rapid and accurate diagnosis is the first step towards treatment in the fight against infectious disease.
Small nanoparticles bring big improvement to medical imaging
If you're watching the complex processes in a living cell, it is easy to miss something important-especially if you are watching changes that take a long time to unfold and require high-spatial-resolution imaging.
More Infectious Diseases Current Events and Infectious Diseases News Articles
 |
Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases: Expert Consult Premium Edition - Enhanced Online Features and Print by Gerald L. Mandell (Author) After thirty years, PPID is still the reference of choice for comprehensive, global guidance on diagnosing and treating the most challenging infectious diseases. Drs. Mandell, Bennett, and Dolin have substantially revised and meticulously updated, this new edition to save you time and to ensure you have the latest clinical and scientific knowledge at your fingertips. With new chapters, expanded and updated coverage, increased worldwide perspectives, and many new contributors, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 7th Edition helps you identify and treat whatever infectious disease you see. And, as an Expert Consult title with enhanced online features, this updated 7th edition comes with convenient access to the full text online, regular... |
 |
Infectious Diseases: A Clinical Short Course, Second Edition (LANGE Clinical Medicine) by Frederick Southwick (Author) Gain a full understanding of clinical infectious diseases in just thirty days A Doody's Core Title! No other resource makes clinical infectious diseases more manageable and easy to master than Infectious Diseases: A Clinical Short Course. This one-of-a-kind self-instruction tool is organized by system/region as opposed to pathogens -- simulating how common pathogens and disorders would be encountered in rounds or in practice. For this reason, this remarkable resource is unsurpassed for learning how to associate pathogens with their corresponding impact on actual patients. Features: A true, concise “short course” format that can be read and understood in the span of a 30-day infectious disease rotation Numerous case examples... |
 |
Clinical Infectious Disease by David Schlossberg (Editor) This clinically-oriented, user-friendly text is the best on the market for infectious disease. Complete and comprehensive, Schlossberg's text will be an effective reference for any practitioner who may encounter these afflictions. The orientation of the volume is multi-faceted: in addition to the traditional organization of organ system and pathogen-related information, this text includes specific sections on the susceptible host, travel-related infections, nosocomial infections, infections related to trauma, and bioterrorism. The information on post-surgical infections will be of great interest to practicing surgeons. Informative algorithms, tables, and high-quality color photographs supplement many of the chapters in this conveniently-sized volume. For practicality and ease of use, one... |
 |
Infectious Diseases, Second Edition (EXPERT GUIDE SERIES- AMERICAN COLLEGE OF PHYSICIANS) by James S. Tan (Editor), Michael J. Tan (Editor), Robert A. Salata (Editor), Thomas M. File Jr. (Editor) Here s the expert guidance practitioners need to diagnose and treat the most commonly encountered infections! This fully revised and updated New Edition keeps readers current with the latest etiologic agents, the most appropriate diagnostic tests, and the most effective management options. The 2nd Edition features new chapters on Antimicrobial Agents for the Primary Care Physician and Prosthetic Joint Infections. FEATURES: -Examines infections of the central nervous system, heart and blood vessels, gastrointestinal tract, genitourinary system, respiratory tract, skeletal system, and the skin. -Features individual chapters on HIV, herpes virus, Lyme disease, and malaria. -Puts key information at the reader s fingertips with diagnostic and treatment tables throughout the text. -Reviews... |
 |
Infectious Disease: A Scientific American Reader (Scientific American Readers) by Scientific American (Editor) The international public health scare that resulted last year when a man infected with multidrug-resistant tuberculosis flew overseas from the United States and back illustrates both the fear and the potential impact of highly infectious diseases in a global age. At a time when scientists warn of the potential for an influenza epidemic to rival the deadly outbreak of 1919 and newspapers feature alarming headlines about incidences of mad cow disease, infectious disease will be a critical area of concern and scientific study in the twenty-first century. Infectious Disease collects thirty of the most exciting, innovative, and significant articles on communicable illness published in the pages of Scientific American magazine since 1993. With sections devoted to viral infections,... |
 |
Case Studies in Infectious Disease by Peter Lydyard (Author), Michael Cole (Author), John Holton (Author), Will Irving (Author), Nino Porakishvili (Author), Pradhib Venkatesan (Author), Kate Ward (Author) Case Studies in Infectious Disease presents forty case studies featuring the most important human infectious diseases worldwide. Written for students of microbiology and medicine this book describes the natural history of infection from point of entry of the pathogen through pathogenesis, followed by clinical presentation, diagnosis and treatment. Five core sets of questions are posed in each case. What is the nature of the infectious agent, how does it gain access to the body, what cells are infected, and how does the organism spread? What are the host defense mechanisms against the agent and how is the disease caused? What are the typical manifestations of the infection and the complications that can occur? How is the infection diagnosed and what is the... |
 |
Infectious Disease Epidemiology: Theory And Practice by Kenrad E., M.D. Nelson (Author), Carolyn F. Masters, Ph.D. Williams (Author) This thorough revision contains new chapters on principles of immunology, measles and polio, meningococcal infections, including pneumococcal, and influenza infections. The chapter on emerging infections has been divided into one of mosquito borne infections and includes West Nile Virus, Rift V and Dengue as well as other arthropod borne infections. SARS and Monkey Poxare included in the new chapter. All other chapters have been updated. |
 |
The A to Z of Infectious Diseases (Concise Encyclopedia) by Carol Turkington (Author), Bonnie Lee, M.d. Ashby (Author) In the past 25 years, more than 30 new germs affecting humans have emerged onto the medical scene, most of them rising from animals. New diseases like the avian flu, Ebola, SARS, and weaponized viruses such as anthrax and smallpox pose a growing danger to the world. With the threat of infectious diseases remaining constant, it is essential to have clear and concise information on this topic. "The A to Z of Infectious Diseases" provides more than 600 up-to-date entries covering the latest research, new treatments and vaccines, and rising diseases such as mad cow disease. Appendixes include drugs used to treat infectious diseases, tips for home disinfection, and lists of helpful organizations and publications, making this the ultimate resource for knowledge about infectious diseases. Topics... |
 |
Current Diagnosis & Treatment In Infectious Diseases (Current Diagnosis and Treatment in Infectious Diseases) by Walter R. Wilson (Author) Numerous quick-access boxes and tables summarize key information on one of the leading causes of death. This title covers the essentials of diagnosis, syndromes in children and adults, and treatments, including first and second-choice options. It blends practice-oriented, authoritative coverage with just the right amount of microbiology for understanding diagnostic and management decisions. |
 |
Infectious Diseases (Infectious Diseases ( Gorbach )) by Sherwood L Gorbach (Editor), John G Bartlett (Editor), Neil R Blacklow (Editor) Tufts Univ. School of Medicine, Boston, MA. Provides comprehensive guidelines on the diagnosis, treatment, and prevention of every infectious disease seen in current clinical practice. Discusses new information on hospital infections, bioterrorism, toxic shock syndrome, West NIle virus, hepatitis, and more. Previous edition: c1998. DNLM: Communicable Diseases. |
| © 2009 BrightSurf.com |